Castle Wealth Management LLC Acquires 1,842 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Castle Wealth Management LLC increased its holdings in UnitedHealth Group by 85.2%, adding 1,842 shares, bringing its total to 4,005 shares valued at approximately $1,249,000.
• Significant institutional activity included Nuveen LLC acquiring a new position worth $3.84 billion, and Vanguard Group increasing its stake by 6.6% to hold over 90 million shares.
• Analysts have varied opinions on the stock, with Goldman Sachs initiating coverage with a "buy" rating and a price target of $406.00, while Oppenheimer reduced its target from $400.00 to $325.00.

Castle Wealth Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 85.2% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,005 shares of the healthcare conglomerate's stock after purchasing an additional 1,842 shares during the period. Castle Wealth Management LLC's holdings in UnitedHealth Group were worth $1,249,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Nuveen LLC purchased a new position in UnitedHealth Group during the first quarter worth $3,846,764,000. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the period. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the period. National Bank of Canada FI boosted its stake in shares of UnitedHealth Group by 137.8% during the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock valued at $859,518,000 after purchasing an additional 950,928 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock valued at $3,702,736,000 after purchasing an additional 847,054 shares during the period. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They issued a "buy" rating and a $406.00 price objective for the company. Zacks Research raised shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research note on Monday, October 6th. Oppenheimer lowered their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Bank of America upped their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 8th. Finally, Sanford C. Bernstein boosted their target price on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an "outperform" rating in a report on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $385.13.

UnitedHealth Group Stock Performance

UNH opened at $361.29 on Thursday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market cap of $327.21 billion, a P/E ratio of 15.65, a price-to-earnings-growth ratio of 2.36 and a beta of 0.47. The firm's 50-day moving average price is $335.48 and its 200-day moving average price is $341.42.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the company earned $6.80 EPS. The business's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.